Official Statement of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) on Electronic Cigarettes and IQOS®
Arch Bronconeumol (Engl Ed). 2019 Nov;55(11):581-586.
doi: 10.1016/j.arbres.2019.04.023.
Epub 2019 Jun 21.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Neumología, Hospital Clínico Universitario INCLIVA, Universidad de Valencia, Valencia, España. Electronic address: jaimesignescosta@gmail.com.
- 2 Servicio de Neumología, Hospital Universitario 12 de Octubre, Universidad Complutense, Madrid, España.
- 3 Unidad de Neumología, Hospital Universitario Fundación Alcorcón, Universidad Rey Juan Carlos, Madrid, España.
- 4 Unidad de Neumología, Hospital Universitario del Vinalopó, Elche, España.
- 5 Servicio de Neumología, Complejo Hospitalario de Santiago de Compostela, Santiago de Compostela, España.
- 6 Servicio de Neumología. Hospital Universitario Virgen de la Victoria, Málaga, España.
- 7 Unidad Especializada en Tabaquismo, Hospital Clínico San Carlos, Madrid, España.
Abstract
The use of novel tobacco products, particularly the electronic cigarette (EC) and partial tobacco combustion devices (HnB systems: Heat not Burn), has increased exponentially, particularly among adolescents and young people. The health authorities and scientific societies have shown concern about issues surrounding safety and effectiveness (as a method of smoking cessation). A study of the available scientific evidence has concluded that the safety of the vapor or fumes inhaled by the users of these devices cannot be guaranteed. Contradictory results from various clinical trials and meta-analyses also mean that these devices cannot be recommended for their effectiveness in cessation, especially when safe and effective treatments are available to help quit smoking (varenicline, nicotine replacement therapy, and bupropion, combined with psychological counseling).
Keywords:
Cigarrillo electrónico; Effectiveness; Eficacia; Electronic cigarette; IQOS®; Riesgos; Risks; Safety; Seguridad; Tabaco; Tobacco.
Copyright © 2019 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Aerosols
-
Cardiovascular Diseases / etiology
-
Electronic Nicotine Delivery Systems* / statistics & numerical data
-
Humans
-
Neoplasms / etiology
-
Pulmonary Medicine*
-
Respiratory System / drug effects
-
Smoking Cessation
-
Societies, Medical*
-
Spain
-
Thoracic Surgery*
-
Tobacco Use Cessation Devices / adverse effects*
-
Tobacco Use Cessation Devices / statistics & numerical data